DAMGO drug
Evidence from:
primary |
all sources
Related entities (15)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| DAMGO | protective_against | alcohol | — | 1 |
| DAMGO | targets | amygdala | — | 1 |
| DAMGO | interacts_with | cAMP | — | 1 |
| DAMGO | targets | cortex | — | 1 |
| DAMGO | targets | dorsal striatum | — | 1 |
| DAMGO | associated_with | GDP | — | 1 |
| DAMGO | targets | hypothalamus | — | 1 |
| DAMGO | targets | NAc | — | 1 |
| DAMGO | interacts_with | NAc core | — | 1 |
| DAMGO | targets | OPRM1 | — | 2 |
| DAMGO | interacts_with | OPRM1 | — | 3 |
| DAMGO | targets | substantia nigra | — | 1 |
| DAMGO | targets | thalamus | — | 1 |
| DAMGO | targets | VTA | — | 1 |
| DAMGO | interacts_with | VTA | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. (2020)
- Pharmacogenetics of OPRM1. (2014)
- Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G. (2014)
- Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. (2013)
- Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012)
- A genetic determinant of the striatal dopamine response to alcohol in men. (2011)
- AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. (2011)
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| damgo | drug | 7 | 27 |
| [3h]-d-ala2, n-mephe4, gly-ol]-enkephalin | drug | — | — |
| d-ala2-mephe4-gly-ol5-enkephalin | drug | — | — |
| [d-ala2,n-mephe4,gly-ol5]-enkephalin | drug | — | — |
| [d-ala 2, n-mephe4, gly-ol]-enkephalin | drug | — | — |
| [d-ala2, n-mephe4, gly-ol]-enkephalin | drug | — | — |